News
HC Wainwright & Co. Reiterates Neutral on RAPT Therapeutics
10 Apr 24
News, Reiteration, Analyst Ratings
RAPT Therapeutics Highlights Results From Phase 2 Trial Of Tivumecirnon In Combination With Anti-PD-1 Immunotherapy In CPI-Experienced Head And Neck Cancer Patients
9 Apr 24
News, FDA
JP Morgan Maintains Neutral on RAPT Therapeutics, Lowers Price Target to $13
27 Mar 24
News, Price Target, Analyst Ratings
RAPT Therapeutics: Q4 Earnings Insights
7 Mar 24
Earnings
RAPT Therapeutics Q4 EPS $(0.80) Beats $(0.86) Estimate, Cash Balance of $158.9M as of December 31, 2023
7 Mar 24
Earnings, News
RAPT Therapeutics Announces Multiple Late-Breaking Presentations At The Upcoming American Association For Cancer Research Annual Meeting
5 Mar 24
Biotech, News, General
UBS Downgrades RAPT Therapeutics to Neutral, Lowers Price Target to $10
22 Feb 24
News, Downgrades, Price Target, Analyst Ratings
Rivian Automotive Reports Q4 Loss, Joins Etsy, Lucid Group And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
22 Feb 24
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
What's Going On With RAPT Therapeutics Stock On Wednesday?
21 Feb 24
Analyst Color, Biotech, Equities, News, Downgrades, Analyst Ratings, Movers, Trading Ideas, General
Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
21 Feb 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
12 Health Care Stocks Moving In Wednesday's Intraday Session
21 Feb 24
Movers
Leerink Partners Downgrades RAPT Therapeutics to Market Perform, Announces $10 Price Target
21 Feb 24
News, Downgrades, Price Target, Analyst Ratings
HC Wainwright & Co. Downgrades RAPT Therapeutics to Neutral
21 Feb 24
News, Downgrades, Analyst Ratings
Crude Oil Moves Lower; Summit Therapeutics Shares Plummet
20 Feb 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Global, Intraday Update, Markets, Trading Ideas
Cantor Fitzgerald Downgrades RAPT Therapeutics to Neutral
20 Feb 24
News, Downgrades, Analyst Ratings
Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
20 Feb 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
12 Health Care Stocks Moving In Tuesday's Intraday Session
20 Feb 24
Movers
Why Is Inflammatory Disease/Oncology-Focused RAPT Therapeutics Shares Tumbling Today?
20 Feb 24
Biotech, News, Health Care, FDA, Movers, General
Dow Dips Over 100 Points; US Leading Economic Index Falls In January
20 Feb 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets, Trading Ideas
Nasdaq Down 1%; Capital One Set To Buy Discover
20 Feb 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets, Trading Ideas
Press releases
RAPT Therapeutics Announces Promising Results from Phase 2 Trial of Tivumecirnon in Combination with Anti-PD-1 Immunotherapy in CPI-Experienced Head and Neck Cancer Patients
9 Apr 24
Press Releases
RAPT ALERT: Bragar Eagel & Squire, P.C. is Investigating RAPT Therapeutics, Inc. on Behalf of RAPT Stockholders and Encourages Investors to Contact the Firm
11 Mar 24
News, Legal, Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of RAPT Therapeutics, Inc. - RAPT
11 Mar 24
Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of RAPT Therapeutics, Inc. - RAPT
7 Mar 24
News, Legal, Press Releases
RAPT Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
7 Mar 24
Earnings, Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of RAPT Therapeutics, Inc. - RAPT
3 Mar 24
Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of RAPT Therapeutics, Inc. - RAPT
28 Feb 24
News, Legal, Press Releases
RAPT Therapeutics, Inc. (RAPT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
26 Feb 24
Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of RAPT Therapeutics, Inc. - RAPT
21 Feb 24
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of RAPT Therapeutics, Inc. - RAPT
21 Feb 24
RAPT Investigation Alert: Kessler Topaz Meltzer & Check, LLP is Investigating Securities Fraud Claims on Behalf of Investors of RAPT Therapeutics, Inc. (NASDAQ: RAPT)
21 Feb 24
News, Legal, Press Releases
Investigation of RAPT Therapeutics, Inc. (RAPT) Announced by Holzer & Holzer, LLC
20 Feb 24
News, Legal, Press Releases